14 October 2015
Assura plc
Director/PDMR Shareholdings
Assura plc ("Assura"), the leading primary care property investor and developer announces that following dealings by the directors and persons discharging managerial responsibilities ("PDMRs") in the shares of Assura as set out in in the prospectus dated 24 September 2015 and the RNS dated 25 September 2015 their beneficial interests, including direct and indirect holdings, are as follows:
Directors
|
Number of Ordinary Shares on 31 March 2015 |
Number of Ordinary Shares on 14 October 2015 |
Simon Laffin (Chairman) |
3,138,578 |
3,338,578 |
Graham Roberts (Chief Executive) |
3,100,000 |
6,500,000 |
Jonathan Murphy (Finance Director) |
534,947 |
1,940,6041 |
Jenefer Greenwood |
97,256 |
117,256 |
David Richardson |
359,998 |
414,835 |
1 includes 341,303 shares transferred from Jonathan Murphy's share dealing account on 14 October 2015 into his SIPP & ISA accounts at an average price of 53.75 pence per share.
Other PDMRs |
Number of Ordinary Shares on 31 March 2015 |
Number of Ordinary Shares on 14 October 2015 |
Orla Ball |
- |
9,733 |
Paul Carroll |
- |
50,000 |
Andrew Darke |
147,988 |
978,739 |
Carolyn Jones |
- |
30,000 |
Spencer Kenyon |
38,571 |
121,285 |
This notification is made in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
- Ends -
For more information, please contact:
Assura plc |
Tel: 01925 420660 |
Orla Ball Carolyn Jones |
|
Finsbury |
Tel: 0207 251 3801 |
Gordon Simpson |
|
Notes to Editors
Assura is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington and listed on the London Stock Exchange, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2015, Assura's property portfolio was valued at £931 million.
Further information is available at www.assuraplc.com .